Gonzales, Nathalie E.
HRN: 26-83-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2025
CLINDAMYCIN 150MG (CAP)
03/18/2025
03/22/2025
ORAL
150mg
Every 6hours
Abscess, Lower Back
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes